发明名称 LYSIS/RESEALING PROCESS AND DEVICE FOR INCORPORATING AN ACTIVE INGREDIENT, IN PARTICULAR ASPARAGINASE OR INOSITOL HEXAPHOSPHATE, IN ERYTHROCYTES
摘要 <p>Lysis/resealing process for preparing erythrocytes which contain an active ingredient (e.g. aspariginase or inositol hexaphosphate), the process comprising the following steps: (1) placing a globular concentrate in suspension in an isotonic solution having a haematocrit level which is equal to or greater than 65 %, with refrigeration at from + 1 to + 8 °C, (2) measuring the osmotic fragility based on a sample of erythrocytes from that same globular concentrate, preferably on a sample of the suspension obtained in step (1), (3) lysis and internalisation procedure of the active ingredient, inside the same chamber, at a temperature which is constantly maintained at from + 1 to + 8 °C, comprising allowing the erythrocyte suspension having a haematocrit level which -is equal to or greater than 65% and a hypotonic lysis solution which is refrigerated at from + 1 to + 8 °C to circulate in a dialysis cartridge ; the lysis parameters being adjusted in accordance with the osmotic fragility previously measured; and (4) resealing procedure carried out in a second chamber at a temperature of from + 30 to + 40 °C by means of a hypertonic solution.</p>
申请公布号 CA2892729(A1) 申请公布日期 2006.02.16
申请号 CA20052892729 申请日期 2005.08.04
申请人 ERYTECH PHARMA 发明人 GODFRIN, YANN
分类号 C12M3/06;A61K9/50;A61K31/6615;A61K35/18;A61K38/50;A61K47/46;A61M1/36;C12N1/06;C12N5/078;C12N11/04 主分类号 C12M3/06
代理机构 代理人
主权项
地址